Literature DB >> 35103895

Individualized Graves' disease remission rates conversations: a videographic analysis of medical encounters.

Jessica Hidalgo1, Sebastián Vallejo2, Omar M El Kawkgi1,3,4, Naykky M Singh Ospina5, Spyridoula Maraka1,6,7, Juan P Brito8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35103895     DOI： 10.1007/s12020-022-02989-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.925


× No keyword cloud information.
  7 in total

Review 1.  Graves' Disease.

Authors:  Terry J Smith; Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2016-10-20       Impact factor: 91.245

2.  External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients.

Authors:  Tristan Struja; Marina Kaeslin; Fabienne Boesiger; Rebecca Jutzi; Noemi Imahorn; Alexander Kutz; Luca Bernasconi; Esther Mundwiler; Beat Mueller; Mirjam Christ-Crain; Fabian Meienberg; Fahim Ebrahimi; Christoph Henzen; Stefan Fischli; Marius Kraenzlin; Christian Meier; Philipp Schuetz
Journal:  Eur J Endocrinol       Date:  2017-01-18       Impact factor: 6.664

Review 3.  Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.

Authors:  Vishnu Sundaresh; Juan P Brito; Zhen Wang; Larry J Prokop; Marius N Stan; Mohammad H Murad; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

4.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

5.  Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease.

Authors:  Juan P Brito; Ana Castaneda-Guarderas; Michael R Gionfriddo; Naykky Singh Ospina; Spyridoula Maraka; Diana S Dean; M Regina Castro; Regina M Castro; Vahab Fatourechi; Hossein Gharib; Marius N Stan; Megan E Branda; Rebecca S Bahn; Victor M Montori
Journal:  Thyroid       Date:  2015-10-15       Impact factor: 6.568

6.  Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.

Authors:  Juan P Brito; Stephanie Payne; Naykky Singh Ospina; Rene Rodriguez-Gutierrez; Spyridoula Maraka; Lindsey R Sangaralingham; Nicole M Iñiguez-Ariza; Victor M Montori; Marius N Stan
Journal:  Thyroid       Date:  2020-02-26       Impact factor: 6.568

7.  Preferences of patients and clinicians for treatment of Graves' disease: a discrete choice experiment.

Authors:  Caroline M J van Kinschot; Vikas R Soekhai; Esther W de Bekker-Grob; W Edward Visser; Robin P Peeters; Tessa M van Ginhoven; Charlotte van Noord
Journal:  Eur J Endocrinol       Date:  2021-05-04       Impact factor: 6.664
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.